Pandemic spotlight paves way for global healthcare technology transfer progress.

Pharmanovia’s Chief Operating Officer, Sagar Patel, has written about the significance of technology transfer in pharmaceuticals. He highlights how technology transfer was integral to the global response during the COVID-19 pandemic, as it led to the sharing and transfer of knowledge that ultimately saved lives. Technology transfer has the potential to revolutionize healthcare by allowing the development and production of new medications and treatments on a larger scale. It can also be used to enhance existing medicines through incremental innovation, such as new administration formats or improved excipients. However, Patel notes that technology transfer is not a straightforward process and requires meticulous planning to avoid common pitfalls. This includes initiating a dossier remediation early on, identifying potential risks and implementing mitigation strategies, thoroughly vetting potential partners, and fostering good relationships between the drug developer and contract development and manufacturing organization (CDMO). Patel concludes by emphasizing the importance of establishing a governance framework to facilitate technology transfer and further drive treatment innovation.